Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00791440 · ClinicalTrials.gov registry record · NA
Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT00791440 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 34 participants.
The verdict
NCT00791440, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
This study examines the impact of Cognitive-Behavior Therapy (CBT) on symptoms, physiological arousal, stressors, and the ways to deal with them in individuals with schizophrenia and related disorders. The primary aim of this study is to investigate the role cognitive coping strategies play in mediating the link between stress, physiological arousal, and psychotic symptoms in individuals with schizophrenia during recovery from psychosis.
Interventions
- BEHAVIORAL Cognitive-Behavior Therapy
- OTHER Standard Psychiatric Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2008-11 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00791440
The ClinicalTrials.gov registry entry for NCT00791440 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive-Behavior Therapy is the first listed.
NCT00791440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00791440 about?
NCT00791440 is a clinical study titled "Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy". This study examines the impact of Cognitive-Behavior Therapy (CBT) on symptoms, physiological arousal, stressors, and the ways to deal with them in individuals with schizophrenia and related disorders. The primary aim of this study is to investigate the role cognitive coping strategies play in media...
What is the current status of trial NCT00791440?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2008-11. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00791440?
The interventions under investigation include: Cognitive-Behavior Therapy (BEHAVIORAL), Standard Psychiatric Treatment (OTHER).
Who is sponsoring clinical trial NCT00791440?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.